MY158088A - Stable lipid emulsion containing prostaglandin e1 - Google Patents

Stable lipid emulsion containing prostaglandin e1

Info

Publication number
MY158088A
MY158088A MYPI20095677A MYPI20095677A MY158088A MY 158088 A MY158088 A MY 158088A MY PI20095677 A MYPI20095677 A MY PI20095677A MY PI20095677 A MYPI20095677 A MY PI20095677A MY 158088 A MY158088 A MY 158088A
Authority
MY
Malaysia
Prior art keywords
emulsion containing
lipid emulsion
stable lipid
containing prostaglandin
prostaglandin
Prior art date
Application number
MYPI20095677A
Other languages
English (en)
Inventor
Fukuyama Takayuki
Ozaki Kazuhiko
Hirai Kenichi
Original Assignee
Mitsubishi Tanabe Pharma Corp
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corp, Taisho Pharmaceutical Co Ltd filed Critical Mitsubishi Tanabe Pharma Corp
Publication of MY158088A publication Critical patent/MY158088A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
MYPI20095677A 2007-07-13 2008-07-11 Stable lipid emulsion containing prostaglandin e1 MY158088A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007184358 2007-07-13

Publications (1)

Publication Number Publication Date
MY158088A true MY158088A (en) 2016-08-30

Family

ID=40259458

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20095677A MY158088A (en) 2007-07-13 2008-07-11 Stable lipid emulsion containing prostaglandin e1

Country Status (6)

Country Link
JP (2) JP5890599B2 (zh)
KR (2) KR101588558B1 (zh)
CN (1) CN101743010A (zh)
MY (1) MY158088A (zh)
TW (1) TW200920379A (zh)
WO (1) WO2009011112A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102038639B (zh) * 2010-12-24 2012-05-02 海南碧凯药业有限公司 一种前列地尔注射制剂
CN102198095A (zh) * 2011-05-03 2011-09-28 北京中海康医药科技发展有限公司 一种依前列醇脂肪乳及其制备方法
JP5759804B2 (ja) * 2011-06-27 2015-08-05 富士フイルム株式会社 容器詰製剤
CN107519132A (zh) * 2017-08-29 2017-12-29 辅必成（上海）医药科技有限公司 一种前列地尔的纳米脂肪乳剂
WO2019230964A1 (ja) * 2018-05-31 2019-12-05 富士フイルム株式会社 容器詰水中油型乳化組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2815595B2 (ja) * 1988-12-27 1998-10-27 松本製薬工業株式会社 医療用ガラス製品内表面の金属酸化物処理によるアルカリ等の溶出防止法
JP3268470B2 (ja) * 1992-11-18 2002-03-25 興亜硝子株式会社 溶出防止機能を有するガラス製品の製造方法
JPH0769897A (ja) * 1993-09-01 1995-03-14 Green Cross Corp:The 血中トリグリセリド低下作用剤
JPH07206472A (ja) * 1994-01-12 1995-08-08 Nippon Electric Glass Co Ltd 医薬用ホウケイ酸ガラス
JPH08104620A (ja) * 1994-10-05 1996-04-23 Green Cross Corp:The 薬物含有脂肪乳剤
JPH08175998A (ja) * 1994-12-19 1996-07-09 Takada Seiyaku Kk シリコート容器を用いた凍結乾燥製剤
JPH09235230A (ja) * 1995-12-29 1997-09-09 Hisamitsu Pharmaceut Co Inc イオントフォレーシス用製剤
US6288113B1 (en) * 1997-08-27 2001-09-11 Welfide Corporation Angiogenesis promoters
JP2001328612A (ja) * 2000-05-22 2001-11-27 Daiwa Tokushu Glass Kk 低アルカリガラス容器及びその製造方法
JP2006188474A (ja) * 2005-01-07 2006-07-20 Nichi-Iko Pharmaceutical Co Ltd 安定性に優れた脂肪乳剤

Also Published As

Publication number Publication date
KR20100053541A (ko) 2010-05-20
JPWO2009011112A1 (ja) 2010-09-16
KR101588558B1 (ko) 2016-01-28
WO2009011112A1 (ja) 2009-01-22
KR20150017775A (ko) 2015-02-17
JP5965944B2 (ja) 2016-08-10
TW200920379A (en) 2009-05-16
JP5890599B2 (ja) 2016-03-22
CN101743010A (zh) 2010-06-16
JP2014224131A (ja) 2014-12-04

Similar Documents

Publication Publication Date Title
HK1217440A1 (zh) 含酸的脂質製劑
EP2068886A4 (en) FORMULATIONS CONTAINING A LIPID
IL200384A0 (en) Formation of lipid bilayers
ZA201007612B (en) Lipid composition
HK1212620A1 (zh) 改進的脂質製劑
ZA200901595B (en) Pickering emulsion formulations
IL216142A0 (en) Lipid compositions
ZA200901479B (en) Pickering emulsion formulations
BRPI0818079A2 (pt) composição de lipideo
DK2328552T3 (da) Lipid-formuleringer omfattende en thioleret antioxidant
GB0702248D0 (en) Manufacture of Filled Paper
HK1141986A1 (en) Emulsion compositions
GB0800991D0 (en) Emulsion for use as confectionery filling
EP2201025A4 (en) FUNCTIONAL LIPID BUILDING PRODUCTS
PL2575501T3 (pl) Trwały płynny preparat wysokolipidowy
EP2214625A4 (en) EMULSION COMPOSITION
EP2118843A4 (en) ANTICIPATED PRESENTATION OF TRAVEL INFORMATION
GB0703257D0 (en) Formation of lipid bilayers
PL2245931T3 (pl) Kompozycja emulsji
MY158088A (en) Stable lipid emulsion containing prostaglandin e1
EP2360154A4 (en) DEUTERATED VITAMIN D COMPOUNDS
EP2262536A4 (en) STABILIZING LIPID COMPOSITIONS FOR ORAL PHARMACEUTICAL AGENTS
EP2245930A4 (en) EMULSION COMPOSITION
EP2285379A4 (en) ANALOGUES OF 1-METHYLNICOTINAMIDE
IL198412A0 (en) Pyrazole analogs